| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $381,689,316 ) (Continued on the next page) |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00ES030403 | Nonpersistent chemical exposure, placental development, and maternal pre- and post-pregnancy cardiovascular health | 000 | 5 | NIH | 11/28/2023 | $248,784 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01HL096812 | ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028 | 003 | 13 | NIH | 9/11/2024 | $392,264 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018204 | Building Access to Food through Systems and Solidarity | 002 | 3 | NIH | 6/13/2024 | $423,748 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018204 | Building Access to Food through Systems and Solidarity | 005 | 3 | NIH | 7/10/2024 | $180,199 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AA031417 | Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder. | 001 | 1 | NIH | 8/27/2024 | $0 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AA031417 | Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder. | 000 | 1 | NIH | 8/26/2024 | $708,511 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | OT2CA297569 | SAMBAI: Societal, Ancestry and Molecular Biology Analyses of Inequalities | 000 | 1 | NIH | 7/22/2024 | $108,317 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21DA061660 | Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach | 002 | 1 | NIH | 8/21/2024 | -$227,861 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21DA061660 | Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach | 002 | 1 | NIH | 8/21/2024 | $227,861 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21DA061660 | Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach | 001 | 1 | NIH | 8/1/2024 | $0 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21DA061660 | Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach | 000 | 1 | NIH | 6/27/2024 | $227,861 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01EY034897 | Sensory Substitution and Brain Plasticity Following Vision Loss | 000 | 1 | NIH | 12/12/2023 | $745,798 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01GM056927 | Control of Translation in Herpesvirus Infected Cells - Resubmission - 1 | 000 | 19 | NIH | 12/7/2023 | $392,526 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00HD103910 | Gestational Diabetes Mellitus, Perinatal Depression, and Offspring Neurodevelopmental Phenotype - Diversity Supplement | 002 | 4 | NIH | 8/28/2024 | $108,494 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL157220 | Intradialytic Myocardial Stunning in Hemodialysis Patients - a Novel Cardiovascular Risk Factor | 001 | 3 | NIH | 6/26/2024 | $54,616 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA274100 | Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma | 000 | 3 | NIH | 6/12/2024 | $488,923 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UL1TR001445 | Clinical and Translational Science Award | 002 | 9 | NIH | 7/11/2024 | $0 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00HD103910 | Gestational Diabetes Mellitus, Perinatal Depression, and Offspring Neurodevelopmental Phenotype - Diversity Supplement | 001 | 4 | NIH | 8/27/2024 | $246,509 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | OT2CA290738 | Next Generation T cell therapies for childhood cancers (NexTGen) | 001 | 1 | NIH | 9/6/2024 | $76,492 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UL1TR001445 | Clinical and Translational Science Award | 003 | 9 | NIH | 9/10/2024 | $0 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UH3CA239861 | Breast Cancer Intravoxel-incoherent-motion MRI Multisite (BRIMM) Study - Resubmission - 1 | 002 | 4 | NIH | 9/4/2024 | $494,118 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R34DA059500 | Transformative Optical Imaging of Brain & Behavior in Navigating Genetic Species | 000 | 1 | NIH | 3/15/2024 | $402,100 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T32AI100853 | Training Program in Immunology and Inflammation | 001 | 13 | NIH | 5/8/2024 | $20,004 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30CA275258 | Dissecting the role of redox homeostasis and ferroptosis in lung cancer | 001 | 2 | NIH | 5/7/2024 | $1,280 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30CA275258 | Dissecting the role of redox homeostasis and ferroptosis in lung cancer | 000 | 2 | NIH | 4/3/2024 | $52,694 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T32AI100853 | Training Program in Immunology and Inflammation | 000 | 13 | NIH | 4/12/2024 | $365,100 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T32NS086750 | Integrative Approaches to Explore Cellular Interactions in Neural Circuits | 001 | 10 | NIH | 7/11/2024 | $0 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T32NS086750 | Integrative Approaches to Explore Cellular Interactions in Neural Circuits | 000 | 10 | NIH | 6/28/2024 | $77,356 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL156355 | Addressing antihypertensive medication adherence through EHR-enabled teamlets in primary care - Resubmission - 1 | 002 | 4 | NIH | 6/20/2024 | $62,068 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R33AG058926 | Growing the Geriatric Emergency care Applied Research (GEAR 1.1) network: Expanding and sustaining an emergency care aging study infrastructure. | 003 | 8 | NIH | 8/27/2024 | $778,743 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T32GM136542 | Training Program in Cell Biology | 001 | 5 | NIH | 6/13/2024 | $22,589 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL156134 | Early Signs:digital phenotyping to identify digital biomarkers for predicting burnout and cognitive functioning in ED clinicians (Early Signs) | 000 | 4 | NIH | 7/30/2024 | $717,622 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T32NS086750 | Integrative Approaches to Explore Cellular Interactions in Neural Circuits | 002 | 10 | NIH | 7/18/2024 | $21,663 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30CA288047 | Targeting amyloid beta for myeloid reprogramming in brain metastasis | 002 | 1 | NIH | 5/7/2024 | $0 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30CA288047 | Targeting amyloid beta for myeloid reprogramming in brain metastasis | 000 | 1 | NIH | 1/30/2024 | $52,694 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG077888 | Structural Racism, Resilience, and Premature Cognitive Aging in End-Stage Renal Disease - Revision - 5 | 000 | 3 | NIH | 4/26/2024 | $813,443 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U54CA263001 | NYULH Metastasis Research Network Center (NYULH MetNet Center) | 001 | 3 | NIH | 7/23/2024 | $1,603,811 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH124927 | The Neural Mechanisms of Winner and Loser Effect | 000 | 3 | NIH | 6/24/2024 | $613,227 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23MH120505 | The Digital Phenotype of Bipolar Disorder: Harnessing Technology to Identify Bipolar Mood Symptoms - Revision - 1 | 001 | 6 | NIH | 5/22/2024 | $53,236 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL156355 | Addressing antihypertensive medication adherence through EHR-enabled teamlets in primary care - Resubmission - 1 | 001 | 4 | NIH | 4/29/2024 | $698,268 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG077888 | Structural Racism, Resilience, and Premature Cognitive Aging in End-Stage Renal Disease - Revision - 5 | 001 | 3 | NIH | 6/17/2024 | $124,667 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | DP2AI164318 | The unleashed microbiome of cancer patients as a discovery platform for rational microbiome engineering | 000 | 4 | NIH | 7/9/2024 | $508,500 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG065672 | The aging stem cell niche | 000 | 5 | NIH | 4/18/2024 | $347,475 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T32GM136542 | Training Program in Cell Biology | 000 | 5 | NIH | 4/12/2024 | $580,205 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30CA288047 | Targeting amyloid beta for myeloid reprogramming in brain metastasis | 001 | 1 | NIH | 5/7/2024 | $1,280 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL165208 | Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease | 001 | 2 | NIH | 5/17/2024 | $727,693 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI085166 | Regulation of T cell exit from non-lymphoid tissues | 003 | 12 | NIH | 2/23/2024 | $474,666 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH130603 | Brainstem Modulation of Proactive Coping | 000 | 2 | NIH | 1/22/2024 | $496,515 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR080136 | Molecular Mechanisms in Sweat Gland Development | 000 | 2 | NIH | 4/15/2024 | $525,722 |
|
